Abstract:Crohn's disease (CD) is a chronic inflammatory gastrointestinal disorder. Genetic association studies have implicated dysregulated autophagy in CD. Among risk loci identified are a promoter single nucleotide polymorphism (SNP)( rs13361189 ) and two intragenic SNPs ( rs9637876 , rs10065172 ) in immunity-related GTPase family M ( IRGM) a gene that encodes a protein of the autophagy initiation complex. All three SNPs have been proposed to modify IRGM expression, but reports have been divergent and largely derived from cell lines. Here, analyzing RNA-Sequencing data of human tissues from the Genotype-Tissue Expression Project, we found that rs13361189 minor allele carriers had reduced IRGM expression in whole blood and terminal ileum, and upregulation in ileum of ZNF300P1, a locus adjacent to IRGM on chromosome 5q33.1 that encodes a long noncoding RNA. Whole blood and ileum from minor allele carriers had altered expression of multiple additional genes that have previously been linked to colitis and/or autophagy. Notable among these was an increase in ileum of LTF (lactoferrin), an established fecal inflammatory biomarker of CD, and in whole blood of TNF, a key cytokine in CD pathogenesis. Last, we confirmed that risk alleles at all three loci associated with increased risk for CD but not ulcerative colitis in a case-control study. Taken together, our findings suggest that genetically encoded IRGM deficiency may predispose to CD through dysregulation of inflammatory gene networks. Gene expression profiling of disease target tissues in genetically susceptible populations is a promising strategy for revealing new leads for the study of molecular pathogenesis and, potentially, for precision medicine. NEW & NOTEWORTHY Single nucleotide polymorphisms in immunity-related GTPase family M ( IRGM), a gene that encodes an autophagy initiation protein, have been linked epidemiologically to increased risk for Crohn's disease (CD). Here, we show for the first time that subjects with risk alleles at two such loci, rs13361189 and rs10065172 , have reduced IRGM expression in whole blood and terminal ileum, as well as dysregulated expression of a wide array of additional genes that regulate inflammation and autophagy.

ATG16L1: A multifunctional susceptibility factor in Crohn disease

ATG16L1 polymorphisms are associated with NOD2-induced hyperinflammation

ATG16L1 rs2241880/T300A increases susceptibility to perianal Crohn's disease: An updated meta‐analysis on inflammatory bowel disease risk and clinical outcomes

The Crohn Disease-associated ATG16L1 T300A polymorphism regulates inflammatory responses by modulating TLR- and NLR-mediated signaling

The Crohn's disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response

Heterozygosity for Crohn’s Disease Risk Allele of Atg16L1 Protects from Salmonella Infection

The Crohn’s disease polymorphism, ATG16L1 T300A, alters the gut microbiota and enhances the local Th1/Th17 response

Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis

A common role for Atg16L1, Atg5, and Atg7 in small intestinal Paneth cells and Crohn disease

Interplay of autophagy and innate immunity in Crohn's disease: a key immunobiologic feature

Inflammatory Bowel Disease: Dysfunction of Autophagy?

Heterozygosity for Crohn’s Disease Risk Allele of Protects against Bacterial Infection

Crohn's disease: NOD2, autophagy and ER stress converge

ATG 16 L 1 rs 2241880 polymorphism predicts unfavorable clinical outcomes for colorectal cancer patients in the Chinese population

Among autophagy genes, ATG16L1 but not IRGM is associated with Crohn's disease in Iranians

Association Between Variants of the Autophagy Related Gene - Irgm and Susceptibility to Crohn'S Disease and Ulcerative Colitis: A Meta-Analysis

Mechanism of action of the tuberculosis and Crohn disease risk factor IRGM in autophagy

The role of ATG16L2 in autophagy and disease

Genetic polymorphism in ATG16L1 gene is associated with adalimumab use in inflammatory bowel disease

Crohn's disease IRGM risk alleles are associated with altered gene expression in human tissues

Inflammatory Bowel Disease at the Intersection of Autophagy and Immunity: Insights from Human Genetics